LCDActive
Benign Skin Lesion Removal (Excludes Actinic Keratosis, and Mohs)
L34233
Effective: October 23, 2025
Updated: December 31, 2025
Policy Summary
Medicare covers removal of specified benign skin lesions only when medical necessity is documented; routine cosmetic removal is non-covered and beneficiary-liable. Medical necessity is met if one or more criteria are documented (bleeding, intense itching, pain, signs of inflammation, obstruction/restricted vision, diagnostic uncertainty with concern for malignancy, prior biopsy showing premalignancy/malignancy, or recurrent trauma), with additional specific wart coverage for periocular conjunctivitis and lesion spread, especially in immunocompromised patients.
Coverage Criteria Preview
Key requirements from the full policy
"Policy applies to benign skin lesions including seborrheic keratoses, skin tags, milia, molluscum contagiosum, sebaceous (epidermoid) cysts, moles (nevi), acquired hyperkeratosis (keratoderma), and..."
Sign up to see full coverage criteria, indications, and limitations.